Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality by Lueders, Imke et al.
RESEARCH ARTICLE
Effects of GnRH vaccination in wild and
captive African Elephant bulls (Loxodonta
africana) on reproductive organs and semen
quality
Imke Lueders1,2*, Debbie Young3, Liana Maree4,5, Gerhard van der Horst4,5, Ilse Luther4,5,
Stephan Botha6, Brendan Tindall7, Geoffrey Fosgate8, Andre´ Ganswindt2, Henk
J. Bertschinger8
1 GEOlifes-Animal Fertility and Reproductive Research, Frohmestr. 7, Hamburg, Germany, 2 Endocrine
Research Laboratory, Department of Anatomy and Physiology, Faculty of Veterinary Science, University of
Pretoria, Onderstepoort, South Africa, 3 African Elephant Research Unit, Plettenberg Bay, South Africa,
4 Department of Medical Biosciences, University of the Western Cape, Bellville, South Africa, 5 Department
of Research and Scientific Services, National Zoological Gardens of South Africa, Pretoria, South Africa,
6 African Lion Safari, Cambridge, ON, Canada, 7 Robberg Veterinary Clinic, 56 Longships, Plettenberg Bay,
South Africa, 8 Department of Production Animal Studies, Faculty of Veterinary Science, University of




Although the African elephant (Loxodonta africana) is classified as endangered by the Interna-
tional Union for Conservation of Nature (IUCN), in some isolated habitats in southern Africa,
contraception is of major interest due to local overpopulation. GnRH vaccination has been
promoted as a non-invasive contraceptive measure for population management of overabun-
dant wildlife. We tested the efficacy of this treatment for fertility control in elephant bulls.
Methods
In total, 17 male African elephants that were treated with a GnRH vaccine were examined in
two groups. In the prospective study group 1 (n = 11 bulls, ages: 8–36 years), semen quality,
the testes, seminal vesicles, ampullae and prostate, which were all measured by means of
transrectal ultrasound, and faecal androgen metabolite concentrations were monitored over
a three-year period. Each bull in the prospective study received 5 ml of Improvac® (1000 μg
GnRH conjugate) intramuscularly after the first examination, followed by a booster six
weeks later and thereafter every 5–7 months. In a retrospective study group (group 2, n = 6,
ages: 19–33 years), one examination was performed on bulls which had been treated with
GnRH vaccine for 5–11 years.
Results
In all bulls of group 1, testicular and accessory sex gland sizes decreased significantly after
the third vaccination. In six males examined prior to vaccination and again after more than
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five vaccinations, the testis size was reduced by 57.5%. Mean testicular height and length
decreased from 13.3 ± 2.6 cm x 15.2 ± 2.8 cm at the beginning to 7.6 ± 2.1 cm x 10.2 ± 1.8
cm at the end of the study. Post pubertal bulls (>9 years, n = 6) examined prior to vaccination
produced ejaculates with viable spermatozoa (volume: 8–175 ml, sperm concentration:
410-4000x106/ml, total motility: 0–90%), while after 5–8 injections, only 50% of these bulls
produced ejaculates with a small number of immotile spermatozoa. The ejaculates of group
2 bulls (vaccinated >8 times) were devoid of spermatozoa. Faecal androgen metabolite con-
centrations measured in captive males decreased significantly after the fourth vaccination.
None of the males entered musth during the treatment period.
Conclusions
Our results showed a marked decrease in semen quality, testicle and secondary sex gland
sizes following repeated GnRH vaccinations. After 2–4 years of continuous treatment every
5–7 months, the effects were similar to surgical castration.
Introduction
Gonadotrophin releasing hormone (GnRH) is synthesized in specialized neuroendocrine cells
in the hypothalamus and transported to the anterior pituitary via the hypothalamic-pituitary
portal system, where it induces synthesis and release of the gonadotrophic hormones, follicle
stimulating hormone (FSH) and luteinizing hormone (LH) [1]. Both gonadotrophic hormones
are important for the regulation of male and female gonadal function (gametogenesis and ste-
roidogenesis). In males, this includes the production of spermatozoa and testosterone in the
testes. The concept of GnRH vaccines is based upon the interruption of the hypothalamic-pitu-
itary-gonadal (HPG) axis by stimulating anti-GnRH antibody production. These antibodies
neutralize endogenous GnRH and, subsequently, disrupt the downstream release of gonado-
trophic hormones. Being able to target GnRH in order to suppress testicular function, without
hormonal or surgical intervention, appears to be an elegant method of contraception. This is
often referred to as down-regulation of testicular function in the peer-reviewed literature. Effi-
cacy is, however, dependent on the achieved humoral immunity and may vary between and
within species as well as GnRH vaccine formulations [2]. For instance, it has been shown that
older stallions are more difficult to supress than younger ones [3,4]. While male rats show a
strong response with almost a 100% arrest in spermatogenesis, in male dogs a decrease of only
5% in spermatogenic activity was reported [5].
Commercial GnRH vaccines have been designed for domestic animals and tested in both
sexes of pigs [6], cattle [7] and horses [4,8]. GnRH vaccines have been suggested as means of
pest or feral animal control, and have been tested in several wildlife species, such as white-
tailed deer (Odocoileus virginianus, [9]), bison (Bison bison, [10]) and wild boars (Sus scrofa,
[11]) with moderate to good success. Recent studies indicated that GnRH vaccines could be
useful for the management of androgen driven behaviours in elephants and the hormone
mediated musth condition seen in adult African (Loxodonta africana) and Asian elephant (Ele-
phas maximus) bulls [12–14]. The GnRH vaccine Improvac1 (Zoetis Animal Health, South
Africa) has been frequently used as an extra-label drug in southern Africa to control andro-
gen-related aggressive behaviour and musth in approximately 45 bulls over the past 10 years
[13]. Independent case reports on a male [15] and a female Asian elephant [16] suggest that
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GnRH vaccines are capable of suppressing gonadal function after multiple monthly injections.
After two to three treatments, a decrease in serum testosterone and faecal androgen metabolite
concentration was found in male Asian [17] and African elephants [14], respectively. This was
accompanied by behavioural improvement and/or attenuation or prevention of musth. A rise
in anti-GnRH antibody titres could be confirmed after 3–5 monthly boosters in one female
[16] and after 2–4 monthly boosters in six male Asian elephants [17]. Only one of the above
studies investigated the effects of GnRH vaccines on the reproductive organs in a single Asian
elephant [15] and none monitored the effect on semen quality in either species.
Although African elephant populations are under pressure, in southern Africa fertility con-
trol is warranted as capacities in smaller, fenced game reserves are exceeded. Due to the intra-
abdominal location of the testes, surgical castration is impractical and expensive in these large
animals, especially when conducted in the wild. Laparoscopic vasectomy has also been per-
formed, but requires specialized operators and expensive equipment and is not without risks
for the animal [18]. Vasectomy leads to irreversible infertility in elephant bulls, while andro-
gen-driven behaviours remain unaffected. The aim of this study was to test the effects of the
commercially available GnRH vaccine Improvac1 (Zoetis, South Africa) on the HPG-axis in
elephant bulls. Thus, we hypothesise a castration-like effect to occur on the internal reproduc-
tive organs, semen quality and faecal androgen metabolite concentrations in adolescent and
mature African elephant bulls.
Materials and methods
Study animals
Captive (n = 13) and wild (n = 4) African elephant bulls were used for the study and examined
between March 2011 and April 2014 (Table 1). In the prospective group 1, consisting of nine
captive and two wild elephants, the effects of the GnRH vaccine were studied from prior to or
soon after the primary vaccination, and thereafter every 5 to 12 months for a period of 3 years.
Seven (five captive, two wild) of these bulls were naïve at the time of the first examination. The
first follow-up examination took place either after primary and first booster immunizations
(n = 5) or after three injections (n = 6, primary, first booster after 6 weeks and second booster
five months later, Table 1). The animals in group 2, consisting of four captive and two wild
bulls that had previously been treated with the GnRH vaccine in the same manner for 5–11
years (primary immunisation, first booster after 4–6 weeks followed by boosters every 5–7
months until the date of examination), were examined once only to assess long-term effects of
the vaccine on semen quality and the reproductive organs. Age, shoulder height, calculated
weight, treatment status and number of vaccinations and examinations for all bulls are pro-
vided in Table 1. Body weights were calculated as a mean of two previously published formulas
on weight/height relationship of African elephant bulls [19,20]. This study was carried out in
strict accordance with recommendations in the Guide for the Care and Use of Laboratory Ani-
mals of the National Institutes of Health. The research proposal was approved by the Animal
Use and Care Committee of the University of Pretoria (Certificate # V016-12).
GnRH vaccinations
The treatment protocol for both groups consisted of a primary immunization, followed by a
first booster after 6 weeks, and thereafter boosters every 5–7 months. In group 1, animals were
treated over the examination period of two to three years, in group 2 for 5–11 years. The vac-
cine was administered by deep intramuscular injection into the muscle mass of the hind leg. In
captive elephants, this was mostly delivered by hand injection and occasionally with a dart
gun. Wild bulls were injected by hand under anaesthesia (first injection) or remotely with a
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dart gun from a helicopter, in which case the gluteal muscle mass was targeted. Each immuni-
zation consisted of 5 ml Improvac1 (Zoetis Animal Health, South Africa) containing 1000 μg
GnRH-protein conjugate.
Anaesthesia
In all but one captive bull procedures were carried out under standing sedation with medeto-
midine and butorphanol, as previously described [21]. One captive and all four wild bulls were
fully immobilized using a combination of 12–15 mg etorphine (M99, Novartis Animal Health,
Isando, South Africa) and 10–20 mg detomidine (Domosedan, Zoetis Animal Health, South
Africa), South Africa) according to estimated weight and delivered remotely from a dart gun
fired from a helicopter (wild bulls) or the ground (captive bull). Reversals were achieved with
100–150 mg diprenorphine (M5050, Novartis Animal Health, Isando, South Africa) and atipa-
mezole HCL (Antisedan, Zoetis Animal Health, South Africa) administered intravenously.
Ultrasound examination
Prior to ultrasound examination and semen collection of standing or recumbent bulls, faeces were
removed manually after which the rectum was flushed with water using a hosepipe. Trans-rectal
ultrasound examinations were performed as previously described [22,23]. A portable, battery-
driven ultrasound machine (Logic e, General Electric (GE) Healthcare GmbH, 42655 Solingen,
Germany) equipped with a 2–7 MHz convex probe was used. In elephants up to 11 years of age,
the testes, which are located caudal to the kidneys, could be visualized using a hand-held ultra-
sound probe. In older bulls, an extension handle was necessary to reach the testes. The extension



















GnRH vaccinations at first
examination
Total number
of GnRH vaccinations at
last examination
1 captive 4 group 1 24–27 293–296 4172–4336 2 7
2 captive 4 group 1 24–27 276–287 3595–4025 2 7
3 captive 4 group 1 17–20 240–265 2401–3197 2 7
4 captive 4 group 1 12–15 230–256 2124–3232 2 7
5 captive 3 group 1 8–12 210–212 1566–1657 0 4
6 captive 4 group 1 10–13 225–237 1994–2316 0 8
7 captive 4 group 1 23–26 290–308 4147–4935 0 8
8 captive 4 group 1 23–26 292–310 4230–5029 0 8
9 captive 4 group 1 23–26 297–306 4443–4843 0 8
10 wild 4 group 1 30–33 302 4396 0 5
11 wild 4 group 1 15–18 247 2483 0 5
12 captive 1 group 2 26 293 4034 >5 >8
13 captive 1 group 2 19 248 2662 >5 >8
14 wild 1 group 2 28 317 5046 >8b >8b
15 wild 1 group 2 33 336 5815 >8b >8b
16 captive 1 group 2 20 263 3033 >8b >8b
17 captive 1 group 2 30 336 5815 >8b >8b
Group 1: multiple examinations over time; Group 2: single examination of long-term treated elephants
a elephants were examined over a period of two to three years, therefore age, shoulder height and body weight are given as ranges as they increased over
the course of the study
b exact number of vaccinations for these animals is not known, but each bull had more than 8 injections at the time of examination
https://doi.org/10.1371/journal.pone.0178270.t001
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handle consisted of a 42 cm long hollow steel pipe with a T-shaped handle and a groove at the
other end to hold the ultrasound probe, which was held in place with duct tape. The probe end of
the extension was angled at 45˚ to facilitate the location of each testis (Fig 1).
Six to ten second long ultrasound video recordings, each of the ampullae, prostate, seminal
vesicles and testes, were made for retrospective analysis. Frozen images were used to measure
the length and height of each organ using the largest dimensions in each case. The diameter
was calculated as a mean of both values for statistical analyses. Since accessory sex glands are
mostly asymmetrical or amorphous-shaped organs, the circumference was also measured by
circumscribing the organ. The outlined 2-D images were then used to calculate the respective
areas for statistical analyses. Since testes and accessory sex glands are paired organs, the means
of the combined measurements were calculated.
Semen collection
Two semen collection methods were initially used and then consistently applied in subsequent
examinations of individual bulls. Semen collection of bulls under standing sedation was per-
formed by trans-rectal, manual massage of the prostate and ampullae of the vas deferentia as
previously described for trained [24] or sedated Asian elephants [25]. The position of the
Fig 1. Convex ultrasound probe and steel extension used for transrectal examination of intra-
abdominally situated testicles in elephant bulls.
https://doi.org/10.1371/journal.pone.0178270.g001
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ampullae and prostate was located by means of ultrasound. Once semen started dripping from
the penis, it was collected in 50 ml polypropylene tubes (Greiner centrifuge tubes, Greiner Bio-
One International GmbH, 4550 Kremsmu¨nster, Austria) attached to funnels made from plastic
rectal sleeves. The tubes were changed regularly to collect ejaculatory fractions and to avoid
possible urine contamination of semen samples.
The method used for electro-ejaculation of one captive and four wild immobilised bulls was
similar to the one described by Howard et al. [26]. A portable, battery driven cattle electro-
ejaculator (El Toro 3, Electronic Research Group, Midrand, Johannesburg, South Africa)
equipped with a hand-held probe, specifically designed for elephants, was used. The probe
which was 15 cm in diameter was fitted with three ventral electrodes, each 20 cm by 3 cm and
spaced 3 cm apart. The probe was placed into the rectum dorsal to the urethra at the depth of
the ampullae and prostate. Low voltage stimuli were applied and gradually increased as
described previously [27]. In our case, however, much lower voltages, not exceeding 16 V,
resulted in ejaculation. The number and duration of stimuli was adapted according to the
response of each male (urethral contractions, erection, mushrooming of the glans penis) and
usually consisted of 10 2–4 s stimuli per cycle with 30 s intervals in-between cycles. The stimuli
of the first cycle were just sufficient to cause mild contraction of the anal sphincter. Thereafter,
with each subsequent cycle, the voltage was increased stepwise until ejaculation commenced.
At this stage, the voltage was kept more or less constant but stimulus duration was increased to
approximately 10 s. Ejaculates or ejaculatory fluids were usually obtained within 20 min of the
first cycle and were collected in 50 ml Greiner tubes as described above.
Semen analysis
Total volume was recorded after adding all fractions together. Ejaculatory fractions of each
bull were assessed individually for the presence of spermatozoa. An aliquot of each fraction
was immediately assessed for total and progressive motility and semen smears were made.
Sperm concentration and percentage motile sperm were determined using automated image
analysis techniques. This analysis involved a Nikon Eclipse 50i microscope (IMP, Johannes-
burg, South Africa) with a temperature controlled stage at 37˚C (HS-50, IMP, Johannesburg,
South Africa) and fitted with a Basler 312fc digital camera (Microptic SL, Barcelona, Spain).
Sperm concentration and motility were assessed using a 10x negative phase objective and ana-
lysed with the Sperm Class Analyser (SCA1) (Microptic SL, Barcelona, Spain) version 4.1.0.0
or 5.4.0.0 at 50 frames per second. Chambered Leja1 slides (Leja1 slide, Leja1 Products B.
V., The Netherlands) with a defined volume (3 μl) and depth (20 μm) were loaded by micropi-
pette for automated analysis. All disposables such as slides and pipette tips used were main-
tained at 37˚C. Where sperm concentration was too high for automated analysis, the semen
was diluted in Ham’s F10 culture medium (Sigma-Aldrich, Johannesburg, South Africa). At
least 500 spermatozoa were analyzed for motility with SCA for each elephant. The best quality
semen fraction was used to report total motility, progressive motility, sperm concentration
and sperm morphology for each bull. Semen smears were processed and stained with Sperm-
Blue1 (Microptic SL, Barcelona, Spain) according to van der Horst & Maree [28] and eosin-
nigrosin (Section Reproduction, Veterinary Faculty, University of Pretoria, Pretoria, S.A.)
within 30 min of collection to assess sperm morphology. The eosin-nigrosin smear was made
by mixing pre-heated (37˚C) stain and semen on a pre-heated microscope slide at a 2:1 (stain:
semen) ratio. The stained spermatozoa were evaluated for morphology using bright field
microscopy at 1000x magnification. Evaluation and classification of sperm morphology of 100
spermatozoa per elephant bull was carried out according to the criteria originally described for
the domestic cattle [29,30].
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Faecal sampling and androgen metabolite assay
Faecal samples were collected within 6 hours of defecation from the 11 captive bulls twice
monthly and one week prior to, during and one week after each examination. Faecal matter
was thoroughly mixed during collection and stored at -20˚C until further processing. Frozen
faecal samples were lyophilized, pulverized, and put through a nylon sieve to separate course
material [31]. A weighed amount (approximately 0.05 g) of dried faecal powder was then
extracted with 80% ethanol in water (3 ml) by vortex-mixing for 10–15 min and subsequent
centrifugation for 5 minutes. The faecal extracts were assayed for immunoreactive androgen
metabolites using an enzyme-immunoassay for 5α-Androstan-3β-ol-17-on (Epiandrosterone)
which has been validated in several mammalian species [32, 33] including African and Asian
elephant bulls [34, 35] for measuring faecal androgen metabolite (fAM) concentrations. Serial
dilutions of faecal extracts gave displacement curves that were parallel to the respective stan-
dard curve. Sensitivity of the assay at 90% binding was 3 pg/well and the intra- and inter-assay
coefficients of variation ranged between 2.4 and 11.9%. The assay was performed on microtiter
plates as described by Ganswindt et al. (34) and conducted at the Endocrine Research Labora-
tory at the Faculty of Veterinary Science, University of Pretoria.
Statistical analyses
For the ultrasound related data, descriptive statistics were calculated, histograms were plotted,
and the Anderson-Darling test for normality was performed (MINITAB Statistical Software,
Release 13.32, Minitab Inc, State College, PA, USA) to assess the normality assumption. Data
were transformed using the natural logarithm to improve the distributional form prior to sta-
tistical analysis. The number of GnRH vaccinations was transformed into an ordinal variable
for statistical modelling based on the following criteria: no GnRH vaccinations, 2 vaccinations,
3 vaccinations, 4 vaccinations, and 5 or more vaccinations. Correlations between quantitative
data were assessed by calculating Spearman’s rho. The effect of multiple GnRH vaccinations
was estimated within a general linear modelling approach to adjust for the repeated sampling
of individual elephants. Elephant age was dichotomized based on less than 20 years of age and
height was dichotomized based on the median of the data (287 cm). A random effect term was
included for elephant and a first order autoregressive correlation structure was used to adjust
for repeated measurements. Models included a fixed effects for number of previous GnRH
vaccinations, age, height at the shoulder (used to approximate body weight by formulas
described previously), and time since first vaccination. Post-hoc pairwise comparisons were
adjusted using the Bonferroni method. Statistical analyses were performed in commercially
available software (IBM SPSS Statistics, Version 23, International Business Machines Corp.,
Armonk, NY, USA) and results interpreted at the 5% level of significance. Values are presented
as mean ± standard deviation (SD), unless stated otherwise.
For assessment of the faecal androgen metabolite concentration in group 1, one-way
repeated measure ANOVA was applied.
Results
In this study, it was possible to monitor 11 bulls treated with GnRH (Improvac1) over a
three-year period. Another six elephants (2 wild, 4 captive) that had previously been treated
with Improvac1 more than eight times were examined once only (Table 1).
All bulls were healthy and in good body condition. Application of the vaccine by dart gun
or hand-injection proved equally effective. Only four of the 84 (3.4%) Improvac1 injections
resulted in side-effects. These consisted of local swelling (Fig 2) and/or discomfort at injection
site (n = 2), stiffness in hind legs (n = 1) and mild lameness which lasted one day (n = 1).
Elephant bull GnRH vaccination
PLOS ONE | https://doi.org/10.1371/journal.pone.0178270 September 15, 2017 7 / 21
Ultrasonographic changes of reproductive organs
Size of organs. Dimensions of testes, seminal vesicles, ampullae and prostate at the begin-
ning (0–2 vaccinations) and end of the study (5 vaccinations) are shown in Table 2. In the
seven elephants examined prior to GnRH vaccination, testis size was significantly correlated to
age at the beginning of the study (r = 0.897, p = 0.0062). The mean testicular length and height
of 10 bulls decreased significantly from 13.3 ± 2.6 x 15.2 ± 2.8 cm at the beginning (0–2 injec-
tions) to 7.6 ± 2.1 x 10.2 ± 1.8 cm at the end (after > 5 injections) of the study (p = 0.0009,
t = 6.121, paired t-test, n = 10, Table 2). Similarly, the dimensions of the ampullae, prostate
and seminal vesicles decreased significantly (Table 2).
Negative correlations between age and size-adjusted organ area at the time of examination
and number of vaccinations were found for the testes (Spearman’s rho = -0.728, p < 0.001,
Fig 3A), ampullae (Spearman’s rho = -0.825, p< 0.001, Fig 3B), seminal vesicles (Spearman’s
Fig 2. Photograph of an elephant hindleg showing swelling (circle line) one day after GnRH vaccine
booster.
https://doi.org/10.1371/journal.pone.0178270.g002
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rho = -0.448, p = 0.001, Fig 3C) and prostate glands (Spearman’s rho = -0.436, p = 0.002, Fig
3D) (n = 17, Table 3).
The decrease in testicular and ampullar size was already significant after the second Impro-
vac1 injection. For the seminal vesicle and prostate areas, however, the differences only
became significant after the third and fifth injections, respectively (Table 4). One captive bull
in particular (bull # 9), responded slower compared to the other males in the study. While tes-
tis size also decreased, the size of his seminal vesicles and ampullae remained relatively
unchanged throughout the study.
Ultrasonographic appearance. The testes of all bulls changed from full and round (Fig
4A–4C) at the beginning to oval and amorphous at the end of the study (Fig 4D–4H). The tes-
ticular tissue appeared to be softer and compressed by the intestines (Fig 4D–4G). The echo-
texture was echogenic at the beginning (Fig 4A–4C) but progressively lost echogenicity during
the course of the study (Fig 4D–4G). A consistent finding in elephants treated more than five
times was a dilatation of the testicular vein (Fig 4E and 4F). The colour doppler flow pattern
prior to treatment was diffuse (Fig 4C) whereas after repeated treatments one central vein with
less peripheral flow became evident (Fig 4F). Elephants that were treated more than five times
also had small and deformed testicles (Fig 4D–4H). The appearance of the testicular tissue in
six elephants that had been treated more than seven times was inhomogenouswith hyperechoic
areas (Fig 4G and 4H), possibly signs of parenchymal atrophy (Fig 4G) and degeneration,
resembling fibrosis (Fig 4H).
Prior to treatment, fluid (hypoechoic) was visible in the ampullae of all mature animals (Fig
5A). The fluid content decreased over time which, after three vaccinations, significantly
reduced the size of the ampullae. After five vaccinations, fluid was no longer visible in the
ampullae (Fig 5B). The fluid within the seminal vesicles was clearly visible in most bulls at the
beginning of the study (Fig 5C) and only appeared to be affected after more than four vaccina-
tions. By the end of the study, seminal vesicle fluid had disappeared completely in seven bulls
of group 1. In the remaining animals, small anechoic fluid filling was visible (Fig 5D and 5F).
The size of the prostate also decreased (Fig 5E, pre-treatment); the effect becoming clearly visi-
ble after more than five vaccinations (Fig 5F; Table 4).
Semen collection and evaluation
Penis extrusion of elephants in standing sedation was sometimes spontaneous and probably as
a result of the sedative drugs. If not, extrusion occurred during the cleaning of the rectum and
trans-rectal massaging. In most cases, continuous trans-rectal massaging of the underlying
organs resulted in the development of a fully extended penis. In two cases, urine dribbling was
Table 2. Comparative ultrasound measurements for reproductive organ area, dimesions (length x height) and circumference at start versus end
of the study of group I bulls.
Study Start Study End Study Start Study End Study Start Study End
Organ: Area (cm2) Area (cm2) Length x heighta (cm) Length x heighta (cm) Circumference (cm) Circumference (cm)
Testicle 165.6 ± 54.6 56.5 ± 25.5 13.3 ± 2.6 x 15.2 ± 2.8 7.6 ± 2.1 x 10.2 ± 1.8 46.6 ± 9.3 29.3 ± 5.5
Ampulla 9.1 ± 3.0 2.2 ± 0.5 2.3 ± 0.7 x 5.1 ± 1.1 1.0 ± 0.3 x 3.2 ± 0.5 nm nm
Seminal
Vesicle
28.2 ± 13.7 14.2 ± 14.5 4.1 ± 1.6 x 9.0 ± 1.3 2.2 ± 1.4 x 7.1 ± 1.7 nm nm
Prostate 13.2 ± 6.1 6.8 ± 3.3 3.6 ± 1.1 x 6.2 ± 1.2 2.1 ± 0.8 x 5.5 x 1.8 nm nm
Results for n = 10 elephants at study start (<2 vaccinations) versus study end (5 vaccinations).
a maximum length x height dimension of organ; nm = not measured
https://doi.org/10.1371/journal.pone.0178270.t002
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observed prior to massaging. When the urethra was stimulated in the correct area, however,
urine dribbling ceased and a semen sample was obtained. Urine contamination of some frac-
tions was recorded in four of 31 manual collections. One (bull # 5) of the seven males assessed
prior to treatment was 8 years old and, according to the appearance of reproductive organs,
low testosterone levels and absence of spermatozoa in the ejaculate, was assessed as prepuber-
tal. This male was therefore not incorporated in the semen evaluation over time.
In untreated males, transrectal massage prior to the first vaccination produced ejaculate
volumes of 8–50 ml. Electro-ejaculation of the immobilised naïve wild bulls was highly suc-
cessful and produced ejaculate volumes of 43 ml (bull #11) and 175 ml (bull #10) prior to vac-
cination. Electro-ejaculation of wild bulls on longstanding treatment (group 2; bulls #14 and
#15) produced only drops of sperm-free seminal plasma.
Fig 3. Graphs showing the negative correlation between number of GnRH vaccination and
reproductive organ size in elephants bulls of group 1.
https://doi.org/10.1371/journal.pone.0178270.g003
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Table 5 summarizes the semen quality of bulls prior to treatment and after two, three, four
to five and more than eight vaccinations. In bulls examined prior to treatment (n = 6), ejacu-
late volume, sperm concentration, sperm motility and percentage normal spermatozoa were
recorded (Table 5). The median values of each these variables decreased with increasing num-
bers of vaccine treatments, with no spermatozoa present in ejaculates from bulls given more
than eight vaccinations (Table 5). However, there were strong individual differences. For
example, considerable amounts of ejaculatory fluids were still produced in some bulls, contain-
ing a substantial concentration of spermatozoa even after 4vaccinations. The percentage nor-
mal spermatozoa decreased significantly from 33.8–93.8-% prior to vaccination to only
Table 3. Univariate associations between reproductive organ size and quantitative predictor variables in 17 bull elephants.
Reproductive organ/predictor Estimate (β^)a 95% CIa P value
Testicular area (cm2)
Age (yrs) -0.0024 -0.0490, 0.0442 0.915
Height (cm) -0.0016 -0.0103, 0.0072 0.716
Time since fist vaccination (days) -0.0010 -0.0014, -0.0006 <0.001
Number of previous vaccinations -0.1404 -0.1874, -0.0933 <0.001
Ampullae area (cm2)
Age (yrs) -0.0452 -0.0909, 0.0005 0.052
Height (cm) -0.0095 -0.0176, -0.0013 0.025
Time since fist vaccination (days) -0.0011 -0.0015, -0.0006 <0.001
Number of previous vaccinations -0.1724 -0.2186, -0.1262 <0.001
Seminal vesicle area (cm2)
Age (yrs) 0.0209 -0.0200, 0.0618 0.295
Height (cm) 0.0033 -0.0048, 0.0114 0.401
Time since fist vaccination (days) -0.0008 -0.0014, -0.0002 0.009
Number of previous vaccinations -0.1001 -0.1597, -0.0404 0.002
Prostate area (cm2)
Age (yrs) 0.0202 -0.0234, 0.0637 0.333
Height (cm) -0.0022 -0.0190, 0.0064 0.594
Time since fist vaccination (days) -0.0009 -0.0012, -0.0006 <0.001
Number of previous vaccinations -0.1038 -0.1462, -0.0613 <0.001
a Results presented for data transformed using the natural logarithm
CI = confidence interval
https://doi.org/10.1371/journal.pone.0178270.t003
Table 4. The effect of the number of GnRH vaccinations on areas of four reproductive organs adjusted for age and size of the elephant at the time
of examination. Data presented as the mean (standard error) of model predicted values.
Number of vaccinations
Reproductive organ size (cm2) 0 2 3 4 5 or more P value*
Testes 139.4a,b (1.13) 133.8b (1.13) 77.4c (1.13) 62.9c (1.12) 44.1d (1.11) <0.001
Ampullae 7.9a (1.18) 6.8a,b (1.17) 3.8b,c (1.17) 3.2c,d (1.15) 2.1d (1.12) <0.001
Seminal vesicles 18.6a,b (1.24) 21.8a (1.24) 15.5a,b (1.23) 12.3a,b (1.21) 9.8b (1.18) 0.020
Prostate glands 11.2a (1.2) 13.2a (1.2) 11.0a (1.2) 9.0a (1.19) 6.1b (1.18) <0.001
a-d Means without superscripts (a-d) in common were significantly different (P < 0.05) after Bonferroni correction for multiple post-hoc tests.
*P value based on a mixed-effects linear regression model including adjustment of repeated measurements and height and age of elephant at time of
sampling.
https://doi.org/10.1371/journal.pone.0178270.t004
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0.7–26% after three treatments (six months after the primary vaccination). No spermatozoa
with normal morphology were recorded for all bulls after four or more vaccinations, when
only few or no spermatozoa were present in the ejaculates. Only one bull (bull #9) had a sperm
count of 220x106/ml at this stage. Here, however, no sperm motility was recorded and 43%
detached heads were noted. A consistent finding in all bulls was head-tail separation, which
involved as much as 53–85% of spermatozoa after three vaccinations (Fig 6). All bulls exam-
ined were azoospermic after more than eight treatments and only small amounts of sperm-free
seminal fluid were collected.
Faecal androgen metabolite concentrations
In group 1, median fAM concentrations in 11 captive bulls were predominantly low at the
start of the study, ranging from 0.96–5.29 μμg/g DW, depicting comparable non-musth levels
(overall median: 2.19 μg/g DW). The high variability in individual fAM level detected between
untreated bulls can probably be attributed to the different age classes and social ranks. A signif-
icant reduction in fAM concentrations was seen after four vaccinations (one year after the pri-
mary immunization, Fig 7) with an overall median fAM concentration decreasing by 29% to
1.56 μg/g DW (range: 0.99–2.26 μg/g DW). Concurrently, during the course of the study, none
of these captive males showed any signs of musth.
Discussion
The current study in African elephant bulls showed that repeated injections of the GnRH vac-
cine Improvac1 had significant effects on the reproductive organs, semen quality, fAM con-
centrations, and the suppression of musth.
Fig 4. Ultrasonographic images of elephant bull testicles before and after GnRH vaccination: (A) untreated
wild bull #10; (B) bull #2 after 2 GnRH vaccinations; (C) untreated bull #9, CD mode showing testicular
vasculature; (D) bull #2 after 7 GnRH vaccinations: note loss in size, shape and ecogenicity compared to(B);
(E) same bull #2 showing one large dilated blood vessel (!); (F) CD mode showing difference in vasculature
compared to untreated bull (C) with one enlarged central vessel: (G) Amorphus shaped testicles of bull # 4
with inhomogenous texture regarded as degeneration of parenchyma, after 7 vaccinations; (H) bull #6 after 8
vaccinations showing signs inhomogenous texture regarded as fibrosis. Images A-F adjusted to same scale,
images (G) and (H) are enlarged relatively to the other images (see scale bar); CD = Colour Doppler.
https://doi.org/10.1371/journal.pone.0178270.g004
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Effects on androgen concentrations
The current study clearly demonstrated the suppressive impact of the GnRH vaccine on the
HPG-axis and finally on the Leydig cell function, resulting in decreased fAM concentrations
and thus confirming the findings of previous studies in African [13, 14, 17] and Asian elephant
bulls [12, 15]. The fAM concentrations were significantly reduced and reached baseline con-
centrations, similar to post-musth concentrations reported for adult wild bulls in the Kruger
National Park [31], in all bulls of group 1 after four or more vaccinations. In a study on Asian
Fig 5. Ultrasonographic images of elephant bull accessory sex glands before and after GnRH vaccination:
(A) prior to GnRH vaccination: sperm and fluid filled right and left ampullae of the ductus deferens (arrows)
just before joining the urethra (ur) and (B) after 3 GnRH vaccine treatments, when ampullae yield no content
anymore; (C) Large fluid filled seminal vesicles (arrows) prior to GnRH vaccination and (D) smaller size of the
seminal vesicles and fluid content reduction after 7 vaccinations; (E) left prostatic lobe (arrows) after 2
vaccinations and (F) after 7 GnRH injections, note the size reduction. Image size adjusted to same scale (see
scale bar).
https://doi.org/10.1371/journal.pone.0178270.g005
Table 5. Effect of number of GnRH vaccinations with Improvac® on ejaculate variables observed over the course of the study in African elephant
bulls of group 1.
Number of vaccinations: Ejaculate volume (ml) Sperm conc. (x106 /ml) Total sperm motility (%) Morphology (% normal sperm)
untreated (n = 6)
MEDIAN (range) 32.8 (8–175) 1172.5 (410–4000) 62.5 (0–90) 57.6 (33.8–93.8)
2 vaccinations (n = 6)
MEDIAN (range) 13.8 (7–169.5) 445 (47–1540) 0 (0–68) 53.9 (33.3–78.7)
3 vaccinations (n = 7)
MEDIAN (range) 5.0 (0.5–29) 294 (0–9800) 0 (0–2) 6 (0.7–26)
4–5 vaccinations (n = 8)
MEDIAN (range) 17.5 (0–65) 0.05 (0–220) 0 0
> 8 vaccinations (n = 6)
MEDIAN (range) 0.2 (0–27.8) 0 0 0
https://doi.org/10.1371/journal.pone.0178270.t005
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elephant bulls, a rise in antibody titres was seen after three monthly vaccinations with Impro-
vac1 (600–1200 μg). The antibody titre was negatively correlated with testosterone concentra-
tions [12].
Our findings further indicate that treatment intervals of 5–7 months following the first
booster, delivered six weeks after the primary vaccination, are sufficient to control androgen
secretion and prevent the state of musth during the treatment period. Previous studies also
showed that after a good initial immunization protocol, longer vaccination intervals of 5–7
months are effective in suppressing testosterone levels and musth [12, 13, 36].
By suppressing testosterone, GnRH vaccination could potentially be applied to mitigate
problem elephant cases. Wild African elephant bulls are reportedly more likely to raid crops
[37] and break fences [38] compared to females. Furthermore, the GnRH vaccination could
have several benefits for captive elephant bulls and their handlers in zoos and elephant sanctu-
aries including: i) suppression of testosterone driven aggressive behaviours and musth; ii)
avoiding animal welfare problems such as prolonged separation and chaining during the
musth phase; and iii) facilitating formation of bachelor herds in zoos or multi-male constella-
tions within female groups.
In captive breeding populations in Europe and North America, more male than female ele-
phant calves are born [39]. The housing and management of these excess males as they mature
is a rapidly looming problem. Keeping males that are regularly treated with GnRH vaccine in
stable bachelor groups may be a possible management solution for surplus males. Alterna-
tively, if pre-pubertal vaccination is applied, males may remain part of the female group as
already described in a single Asian elephant male [15] and observed in the wild 15 year-old
Fig 6. Microscopic image of stained elephant spermatozoa 8.5 months after the first GnRH
vaccination (= 3 injections: Primer, 1st and 2nd booster), showing the example of tail and head
separation, stain: SpermBlue®, magnification: x1000.
https://doi.org/10.1371/journal.pone.0178270.g006
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male (bull # 11). In the age group 12–16 years, testosterone output starts to increase and this is
particularly problematic in captive young bulls in South Africa (Bertschinger, personal com-
munication). This is also the age when young bulls in the wild reach puberty and leave their
natal herds [40, 41]. Currently, bulls in musth are hobbled and short leg chains are applied to
restrict movement for extended periods. Access to water and food is restricted and tranquilliz-
ers may even be administered [42]. All these measures present significant welfare issues.
Efforts to suppress musth with GnRH analogues such as leuprolide acetate [43] and deslorelin
implants [44] were largely unsuccessful. The advantage of GnRH vaccines is that they have an
immunological action and do not rely on intervention with exogenous hormones. Further-
more, they are more cost effective than GnRH analogues, fewer treatments are required and
they can be delivered remotely with a dart gun. While the vaccine cannot change learned
behaviours or individual personalities, it may mitigate testosterone driven traits particularly if
applied at a pre-pubertal age.
Fig 7. Boxplots depicting the decline in fecal androgen metabolite (fAM) concentration after numerous GnRH vaccinations in
elephant bulls of group 1. After the fourth injection, a significant reduction in fAM was noticed.
https://doi.org/10.1371/journal.pone.0178270.g007
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Effects on reproductive organs and semen quality
We found a significant decrease in testis size as well as all accessory sex glands after multiple
treatments with the GnRH vaccine. The accessory sex glands, such as seminal vesicles, ampul-
lae of the ductus deferens and prostate were shown to be reliable markers for predicting breed-
ing potential in male elephants [22, 23]. Gonadal atrophy has been described in several GnRH
vaccine studies in various species [5]. The effect of GnRH vaccination on testis size was consid-
erable with a mean reduction in diameter of 60% in our study. This is consistent with a 70%,
40–80% and about 50% reduction in testicular weight of pigs [45], ram lambs [46] and domes-
tic bulls [47] treated with GnRH vaccines, respectively.
Not surprising was the effect of GnRH vaccine treatment on size and fluid content of the
ampulla and prostate of bulls in the current study. The accessory sex glands are androgen-
dependent for normal function. GnRH analogues, which also down-regulate FSH and LH
release, decrease prostate size and are thus commonly used for treatment of benign prostate
hypertrophy in dogs [48] and humans [49], and prostate cancer cancer in humans [50]. The
ampullae of the vas deferens offer temporary sperm storage in elephant bulls [23]. A reduction
in spermatogenesis would thus lead to less luminal content in this paired organ. The effect on
seminal vesicles was also visible, however, androgen deprivation appears to have had less effect
on their fluid content.
From a contraception point of view, the most important effect of the GnRH vaccine Impro-
vac1 was the one on semen quality. Sperm production was altered after three GnRH immuni-
sations, and spermatozoa were absent (azoospermia) after more than four vaccination in 50%
of elephant bulls. The remaining bulls had only few abnormal and immotile spermatozoa pres-
ent in their ejaculates. All these findings on sperm alteration are consistent with those in
mature stallions immunized with a GnRH vaccine [51]. Breeding potential would seem to be
markedly affected after the first three injections (six months) and most elephant bulls could be
expected to be infertile after 4–5 injections (1–1.5 year of treatment). The arrest of spermato-
genesis may not be consistent in all bulls, clearly demonstrated by elephant #9. The accessory
sex glands of this bull were also less affected than the other bulls. Individual responses should
be considered, and the ability to produce viable spermatozoa may be retained for prolonged
periods. Nevertheless, the sperm motility of bull #9 decreased from 35% prior to treatment to
0% after six months, morphology from 34% to 1% after 12 months and only isolated sperm
were observed after 36 months. Azoospermia was seen in all elephant bulls treated for more
than five years and 4/8 bulls treated for three years. An effect of age on response to GnRH vac-
cine could not be confirmed for the elephants in our study.
Side effects and reversibility
Although other studies did not report side effects in elephants treated with GnRH vaccines
[15–18], we noticed a few negative reactions in a small percentage of vaccinations. These tem-
porary side effects were seen as local swelling (Fig 2), stiffness and mild lameness. When Asian
elephants were vaccinated into the neck muscle region, no problems were reported [12, 15].
However, Bertschinger and Sills [13] noted occasional stiffness and swellings in African ele-
phant bulls injected into the neck muscles. The adjuvant used in Improvac1 is a diphtheria
toxoid and animals tend to show greater reactions if it is administered subcutaneously or into
intermuscular fascia. In mares and stallions, minor side effects are seldom seen when Impro-
vac1 is administered by deep intramuscular injection into the gluteal muscle mass [8]. At the
same time, another GnRH vaccine and adjuvant administered to White-tailed deer (Cervus
dama) resulted in abscess and/or granuloma formation in nearly all animals after the first
immunization [52]. Thus, site of injection should be selected according to experiences in
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different species. Larger volumes should be administered in two injection sites. Care should be
taken to ensure deep intramuscular injection to reduce side effects depending on the adjuvant
used.
A very important question, particularly for some species or circumstances, is the reversibil-
ity of GnRH vaccines. We did not plan to test reversibility of the GnRH vaccine in the current
study, but it certainly needs to be investigated. The loss of testosterone at a young age may lead
to retarded development of the penis, testicles and accessory sex glands in elephants [13, 5]. In
a previous study, treatment of a young male Asian elephant discontinued after being immu-
nised every 5–12 months for a period of more than six years. It has now been four years since
the last booster and his testosterone concentration remains at baseline (personnel communica-
tion Charlie Gray, African Lion Safari, Canada, 19.07.2016).
An alerting finding was the ultrasonographic appearance of the testes following a number
of GnRH vaccinations (Fig 4B–4E). The loss of echogenicity and testicular architecture, and
some of the sperm defects (Fig FB-E) observed, are possibly signs of testicular degeneration.
The observations were also made in the mature bulls and indicate that permanent damage
may follow consecutive treatments as early as after 1.5 years. Severe testicular pathologies such
as seminiferous tubule degeneration, segmental tubular aspermatogenesis, decreased cross-
sectional diameter of seminiferous tubules, decreased cytoplasmic volume of Leydig cells,
interstitial fibrosis, and total aspermatogenesis have been observed in White-tailed deer treated
three times with a GnRH vaccine [52]. Although testicular histology has not been performed
on GnRH vaccine-treated elephant bulls, some of our ultrasonographic observations indicate
similar processes could have occurred (Fig 4B–4E). It was not possible to objectively assess bull
behaviour before and at intervals after GnRH vaccine treatment. However, it should be noted
that before commencement of treatment, two of the captive bulls were highly aggressive
towards their handlers and one wild bull was in full musth. The aggressive behaviour and
musth ceased after two immunisations and did not recur by the end of the study. None of the
other bulls showed sexual interest, musth or musth related behaviour throughout the study,
despite many being at an age where musth occurs regularly or intermittently. There was no
noticeable change to the masculine appearance of the males in our study, likely because the
period of observation was relatively short. Even bull #17, who was 34 years at the time of exam-
ination and had been on treatment for 13 years, displayed normal masculine appearance, body
growth rate and tusk growth.
In summary, the complete absence of spermatozoa in ejaculates of long-term treated bulls,
baseline fAM concentrations and a lack of sexual interest suggest a castration-like effect as a
result of GnRH vaccination.
Although our initial results show an impressive effect already within 1.5 years of vaccina-
tion with Improvac1, more research is needed to determine optimal treatment intervals,
reversibility of the treatment, and effects in juvenile versus adult African elephant bulls. Fur-
thermore, the effects on social, reproductive and hierarchical behaviours, possible demo-
graphic impacts and effects on bone metabolism need to be investigated.
Conclusions
The GnRH vaccine Improvac1, originally developed for the pig industry, appears to have a
potent effect on African elephant bulls. Regular boosters at 5–7 month intervals are sufficient
to down-regulate testicular size, testosterone levels and spermatogenesis in male elephants. If
elephants are treated continuously for more than 2–3 years (4–8 times), irreversible effects are
possible. For the use as a contraceptive measure in wild elephant bulls, single-shot, long-acting
vaccines would be more practical. On the other hand this may affect reversibility.
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